"Prealbumin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease.
MeSH Number(s)
D12.776.034.841.450
D12.776.124.727.450
Below are MeSH descriptors whose meaning is more general than "Prealbumin".
Below are MeSH descriptors whose meaning is more specific than "Prealbumin".
This graph shows the total number of publications written about "Prealbumin" by people in Harvard Catalyst Profiles by year, and whether "Prealbumin" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 2 | 3 |
| 1999 | 2 | 1 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 3 | 4 |
| 2008 | 3 | 4 | 7 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 3 | 4 | 7 |
| 2013 | 0 | 2 | 2 |
| 2014 | 5 | 2 | 7 |
| 2015 | 5 | 0 | 5 |
| 2016 | 3 | 0 | 3 |
| 2017 | 0 | 3 | 3 |
| 2018 | 10 | 5 | 15 |
| 2019 | 7 | 6 | 13 |
| 2020 | 2 | 10 | 12 |
| 2021 | 6 | 4 | 10 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Prealbumin" by people in Profiles.
-
Transthyretin binds soluble endoglin and increases its uptake by hepatocytes: A possible role for transthyretin in preeclampsia? Mol Cell Endocrinol. 2023 Feb 15; 562:111851.
-
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis. Circ Cardiovasc Imaging. 2022 11; 15(11):e014645.
-
A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2022 10 01; 7(10):1036-1044.
-
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis. J Am Heart Assoc. 2022 09 20; 11(18):e026308.
-
Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. Am J Cardiol. 2022 10 15; 181:105-112.
-
Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2022 07 21; 23(8):1029-1039.
-
Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement. J Nucl Cardiol. 2022 Oct; 29(5):2748-2760.
-
Understanding Changes in Functional Capacity After TTR Stabilization in Patients With Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2022 07; 15(7):e009387.
-
Nicotine binds to the transthyretin-thyroxine complex and reduces its uptake by placental trophoblasts. Mol Cell Endocrinol. 2022 06 01; 549:111642.
-
Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience. Amyloid. 2022 Jun; 29(2):71-78.